Medimaps Group and Radiobotics have announced a strategic merger aimed at expanding their combined portfolio of AI-driven musculoskeletal imaging technologies. The partnership brings together Medimaps’ expertise in bone health assessment and imaging analytics with Radiobotics’ artificial intelligence platforms for automated musculoskeletal image interpretation. By integrating their technologies, the companies aim to enhance diagnostic precision, streamline clinical workflows, and improve early detection of musculoskeletal conditions such as fractures, osteoarthritis, and osteoporosis. The merger reflects the growing role of artificial intelligence in orthopedic imaging, where automated analytics and decision-support tools are increasingly being used to support clinicians and improve efficiency across radiology and orthopedic care pathways.